oral semaglutide doses Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Now that oral semaglutide (#wegovy)

Wegovy Shot (Injectable Formulation) The Wegovy injection received FDA approval in June 2021 for chronic weight management

Its plasma concentration is approximately 200 ng/ml in young adults (around age 20), but drops to about 80 ng/ml by age 60

| Frequently asked questions | Take home message Wegovy and Ozempic both contain the same drug, semaglutide, but at different doses for different purposes

Heres how to fine-tune your dosage based on your progress: 1

clinical trial registry shows that thousands of studies on GLP-1 receptor agonists are underway now

This improved receptor expression has provided the ability to the recovery process from exercise, athletic injuries, and other soft tissue stressors